The Secret Of Successful Xarelto Lawsuit
Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical firms, including the makers of Xarelto, have a duty to make sure that their drugs are reasonably protected for use - and failure to perform so may be grounds for compensation. Our lawyers are operating challenging to get these hurt by the drug the compensation they may be entitled to.
Even though bleeding is actually a typical complication associated with anticoagulants, it has Full Article been alleged that Xarelto is much more harmful than classic blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This means that, inside the occasion of an emergency, individuals may be at risk for irreversible bleeding troubles, such as life-threatening internal and gastrointestinal hemorrhaging.
In the event you or perhaps a loved a single suffered a critical bleeding event soon after taking Xarelto, you may have legal recourse. For more data, make contact with us nowadays to possess your case reviewed, free of charge of charge.
Compensation Possibilities
xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future health-related bills, lost wages, pain and suffering and, in instances of death, funeral expenditures. In addition, they may be in search of punitive damages, which are typically awarded to punish the defendant and deter other organizations from acting similarly.
Why Are Lawsuits Getting Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding in the event of an emergency. Plaintiffs inside the lawsuits allege significant and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user in the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.
Visit this page for a lot more data on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.